// App-Quantinova.ai

P-0138 : SINGLE INSTITUTION EXPERIENCE WITH S-1 (TEYSUNO) IN DANISH PATIENTS WITH GASTRO-INTESTINAL CANCER

Researchers

Presenter

  • Per Pfeiffer

Principal Investigators

  • Petter Thomseth-Lerstrom

  • Helle Jensen

  • Lene Vestermark

  • Merete Krogh

  • Katrine Schonnemann

Medical Centers

  • Department of Oncology, Odense University Hospital, Odense, Denmark

  • Dept. of Oncology, Odense C, Denmark

Locations

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hand foot syndrome

  • Intestinal cancer

  • Colorectal Cancer

  • Gastric Cancer

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Capecitabine

  • Oxaliplatin

  • Epirubicin

  • Tegafur/gimeracil/oteracil

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved